1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Relapsing Multiple Sclerosis (RMS): new trials by email Literature Review of Relapsing Multiple Sclerosis (RMS) trials Research Report on Relapsing Multiple Sclerosis (RMS)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Efficacy and Safety of Fingolimod (Gilenya) 0.5 mg in Chinese Patients With Relapsing Multiple Sclerosis (RMS) Patients Fingolimod 0.5mg - Relapsing Multiple Sclerosis (RMS) | Phase 4 | Completed | Novartis Pharmaceuticals | 98 | 2021-02-20 | 2026-01-13 |
China (1)